Consequently, interference in the NF-E2 binding site, as seen in haplotype D, may result in decreased α-globin gene expression in humans; even so, the presence of this HS-40 haplotype in heterozygosity is not enough to cause α-thalassemia. This evidence concerns the gene NFE2 and thalassemia.